These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7182204)

  • 1. [Results of a multicenter study on the effect on serum triglycerides and cholesterol administration of carnitine in chronic uremia patients undergoing periodic hemodialysis treatment].
    Toigo G; Situlin R; Dardi F; Bazzato G; Vasile A; Tesio F; Ciman M; Guarnieri GF
    G Clin Med; 1982; 63(11-12):841-9. PubMed ID: 7182204
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of long-term treatment with L-carnitine on dyslipemia in hemodialysis patients].
    Dionisio P; Bergia R; Caramello E; Graziola M; Valenti M; Bajardi P; Barbera L; Voglino F
    Minerva Med; 1985 Feb; 76(6):229-34. PubMed ID: 3974937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of L-carnitine supplementation on lipid metabolism of renal failure, dialysis-dependent children and adolescents].
    Böhles H; Michalk D; von Wendt-Göknur E
    Infusionstherapie; 1991 Oct; 18(5):224-6. PubMed ID: 1769735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electromyographic changes induced by oral carnitine treatment in dialysis patients.
    Albertazzi A; Spisni C; Del Rosso G; Palmieri PF; Rossini PM
    Proc Clin Dial Transplant Forum; 1980; 10():1-6. PubMed ID: 7346837
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum lipids in uraemic patients on regular haemodialysis.
    Pierides AM; Weightman D; Goldfinch M; Tsoukantas A; Kerr DN
    Proc Eur Dial Transplant Assoc; 1976; 12():397-402. PubMed ID: 935128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Short-term effect of treatment with oral DL-carnitine and intravenous L-carnitine in chronic uremia patients undergoing hemodialytic therapy].
    Demelia L; Solinas A; Gogoni G; Marongiu F; Besson A
    Recenti Prog Med; 1982 May; 72(5):664-74. PubMed ID: 6753066
    [No Abstract]   [Full Text] [Related]  

  • 7. Advances in carnitine in chronic uremia.
    Guarnieri G; Biolo G; Vinci P; Massolino B; Barazzoni R
    J Ren Nutr; 2007 Jan; 17(1):23-9. PubMed ID: 17198928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis.
    Guarnieri GF; Ranieri F; Toigo G; Vasile A; Ciman M; Rizzoli V; Moracchiello M; Campanacci L
    Am J Clin Nutr; 1980 Jul; 33(7):1489-92. PubMed ID: 7395772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of L-carnitine supplementation on lipid parameters in hemodialysis patients.
    Elisaf M; Bairaktari E; Katopodis K; Pappas M; Sferopoulos G; Tzallas C; Tsolas O; Siamopoulos KC
    Am J Nephrol; 1998; 18(5):416-21. PubMed ID: 9730566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Charcoal-induced lipid reduction in uremia.
    Friedman EA; Feinstein EI; Beyer MM; Galonsky RS; Hirsch SR
    Kidney Int Suppl; 1978 Jun; (8):S170-6. PubMed ID: 278886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of D-L carnitine on the metabolism of plasma lipids, copper and zinc in hemodialysis].
    Bustamante J; Martín Mateo MC; Bustamante R; San Segundo D
    Rev Clin Esp; 1983 Jan; 168(1):41-3. PubMed ID: 6844679
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of L-carnitine administration on erythrocyte survival in haemodialysis patients.
    Arduini A; Bonomini M; Clutterbuck EJ; Laffan MA; Pusey CD
    Nephrol Dial Transplant; 2006 Sep; 21(9):2671-2. PubMed ID: 16611680
    [No Abstract]   [Full Text] [Related]  

  • 13. Total carnitine and acylated carnitine ratio: relationship of free carnitine with lipid parameters in pediatric dialysis patients.
    Marín VB; Azocar M; Molina M; Guerrero JL; Ratner R; Cano F
    Adv Perit Dial; 2006; 22():130-5. PubMed ID: 16983956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-carnitine and platelet aggregation in uremic patients subjected to hemodialysis.
    Bellinghieri G; Savica V; Barbera CM; Ricciardi B; Egitto M; Torre F; Valentini G; D'Iddio S; Bagiella E; Mallamace A
    Nephron; 1990; 55(1):28-32. PubMed ID: 2141109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of cellulose diacetate dialysis membranes on lipids and lipoproteins in uremic patients].
    Jakić M; Rupcić V; Stipanić S; Samardzija G; Bilandzija M; Zibar L; Mihaljević D; Milas J
    Lijec Vjesn; 1997 Feb; 119(2):56-9. PubMed ID: 9297037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid metabolism in uremia: effect of regular hemofiltration and hemodialysis treatment.
    Henning HV; Balusek E
    J Dial; 1977; 1(6):595-605. PubMed ID: 608870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose of L-carnitine increases platelet aggregation and plasma triglyceride levels in uremic patients on hemodialysis.
    Weschler A; Aviram M; Levin M; Better OS; Brook JG
    Nephron; 1984; 38(2):120-4. PubMed ID: 6472539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newer aspects of carnitine metabolism in uremia.
    Savica V; Calvani M; Benatti P; Santoro D; Monardo P; Mallamace A; Savica R; Bellinghieri G
    Semin Nephrol; 2006 Jan; 26(1):52-5. PubMed ID: 16412827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug treatment of hypertriglyceridaemia in chronic uraemic patients: preliminary report on D,L-carnitine and thiadenol.
    Giorcelli G; Vacha G; Icardi GP
    Proc Eur Dial Transplant Assoc; 1980; 17():367-71. PubMed ID: 7243794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of L-carnitine on respiratory function tests in children undergoing chronic hemodialysis.
    Kavukçu S; Türkmen M; Salman S; Onvural B; Oktay G; Karaman O; Cevik NT
    Turk J Pediatr; 1998; 40(1):79-84. PubMed ID: 9673532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.